Aegle Therapeutics Corp — Form D
Aegle Therapeutics Corp of Woburn, MA, a company, filed a Form D exempt-offering notice with the SEC on 2020-01-07. $4.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-01-07
- Form: D
- Accession: 0001797825-20-000001
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $4.0M
- Investors: 7
- Date of first sale: 2020-01-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-357408
Issuer
- Name: Aegle Therapeutics Corp
- CIK: 0001797825
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 400 TradeCenter Drive, Woburn, MA, 01801
- Phone: 781-918-8449
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Steve O'Hara | Director | Pitssburg, PA |
| Robert Ryan | Director | Dallas, TX |
| David Schimel | Director | Woburn, MA |
| Leon Moulder | Director | Woburn, MA |
| Elona Baum | Director | San Francisco, CA |
| Leon Moulder, Jr. | Director | Waltham, MA |
| Shelley Hartman | Director | Woburn, MA |
| Shelley Hartman | Executive Officer | Woburn, MA |
| Evangelos Badiavas | Director | Woburn, MA |
| Evangelos Badiavas | Executive Officer | Woburn, MA |
| Robert Williamson, Jr. | Director | MIAMI SHORES, FL |
| Robert Williamson, Jr. | Executive Officer | MIAMI SHORES, FL |
| Scott Braunstein | Director | Woburn, MA |
| Mikio Tanji | Director | Woburn, MA |
Other filings by this issuer (3)
More